You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

58 search results for: biologics

ERS 2023 | Adult Asthma Symposium: Mini Debate
expert video

ERS 2023 | Adult Asthma Symposium: Mini Debate

Pulmonology
Prof. Ian Pavord moderates a debate between Prof. Vibeke Backer and Dr. Francesca Puggioni about what a patient's lung function should be in order to be defined as achieving clinical remission in adult asthma.
View more
ERS 2023 | Adult Asthma Symposium: Panel Discussion
expert video

ERS 2023 | Adult Asthma Symposium: Panel Discussion

Pulmonology
Profs. Ian Pavord and Vibeke Backer and Dr. Francesca Puggioni and audience members share their views on the proposed framework for clinical remission in severe asthma.
View more
ERS 2023 | Assessing Disease Activity to Better Define On-Treatment Clinical Remission in Pediatric Severe Asthma
expert video

ERS 2023 | Assessing Disease Activity to Better Define On-Treatment Clinical Remission in Pediatric Severe Asthma

Pulmonology
Join pediatric asthma experts Prof. Giorgio Piacentini and Dr. Sharon Dell for an educational program on the topic of remission in pediatric asthma.
View more
ERS 2023 | Burden of Underlying Disease in Pediatric Severe Asthma
expert video

ERS 2023 | Burden of Underlying Disease in Pediatric Severe Asthma

Pulmonology
Join pediatric asthma experts Prof. Giorgio Piacentini and Dr. Sharon Dell for an educational program on the topic of remission in pediatric asthma.
View more
ERS 2023 | Evolving Patient Care: From Symptom Control to On-Treatment ​Clinical Remission​
expert video

ERS 2023 | Evolving Patient Care: From Symptom Control to On-Treatment ​Clinical Remission​

Pulmonology
Join Profs. Ian Pavord and Vibeke Backer and Dr. Francesca Puggioni for an educational program on the topic of clinical remission in severe asthma.
View more
ERS 2023 | On-Therapy Remission in Pediatric Asthma: Where Are We Today?
expert video

ERS 2023 | On-Therapy Remission in Pediatric Asthma: Where Are We Today?

Pulmonology
Join pediatric asthma experts Prof. Giorgio Piacentini and Dr. Sharon Dell for an educational program on the topic of remission in pediatric asthma.
View more
ERS 2023 | Progression of Underlying Disease in Pediatric Severe Asthma
expert video

ERS 2023 | Progression of Underlying Disease in Pediatric Severe Asthma

Pulmonology
Join pediatric asthma experts Prof. Giorgio Piacentini and Dr. Sharon Dell for an educational program on the topic of remission in pediatric asthma.
View more
When is the right time to consider a biologic in patients with CRSwNP?
expert video

When is the right time to consider a biologic in patients with CRSwNP?

Rhinology
Prof. Hellings and Prof. Corso explain that the right time to implement a biologic depends on academic and reimbursement criteria, which vary by country.
View more
ERS 2023 | Pediatric Asthma Symposium: Patient Case Discussion
expert video

ERS 2023 | Pediatric Asthma Symposium: Patient Case Discussion

Pulmonology
Join pediatric asthma experts Prof. Giorgio Piacentini and Dr. Sharon Dell for an educational program on the topic of remission in pediatric asthma.
View more
What treatments may be needed to achieve remission? And In what percentage of patients could remission be a target?
expert video

What treatments may be needed to achieve remission? And In what percentage of patients could remission be a target?

Rhinology
Prof. Hellings and Prof. Corso highlight that disease severity plays a key role in rate and control of remission in CRS.
View more
GINA Asthma Decision Tree
videoanimation

GINA Asthma Decision Tree

Pulmonology
Walk through the GINA decision tree for severe asthma
View more
Why did the definition of control in CRSwNP change between EPOS 2020 and EPOS/EUFOREA 2024?
expert video

Why did the definition of control in CRSwNP change between EPOS 2020 and EPOS/EUFOREA 2024?

Rhinology
Prof. Hellings and Prof. Corso discuss the significance and rationale behind the new definition of CRSwNP.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: BelgiumChange country/region